SWOG clinical trial number
SWOG-7864
Combined Modality Treatment of Residual Gastric Carcinoma Following Initial Surgery
Closed
Phase
Abbreviated Title
Combined Modality Treatment of Residual Gastric Carcinoma Following Initial Surgery
Activated
04/26/1978
Closed
10/04/1979
Publication Information Expand/Collapse
1983
Combined nonsimultaneous radiation therapy and chemotherapy with 5-FU, Doxorubicin, and Mitomycin for residual localized gastric adenocarcinoma: A Southwest Oncology Group pilot study.
1980
Southwest Oncology Group Pilot study of radiotherapy (R) + 5-Fluorouracil (F) + Adriamycin (A) + Mitomycin-C (M) in patients (PTS) with minimal residual gastric cancer (MRGC).